Logo
Flawless Deep Filler Lidocaine – 2 x 1ml (CE)

Flawless Deep Filler Lidocaine – 2 x 1ml (CE)

Flawless

CE-marked hyaluronic acid dermal filler (medical device)
  • CE Certified hyaluronic acid dermal filler under EU medical device/PPE regulations (Flawless range explicitly advertised as CE Marked on manufacturer and distributor sites).
  • Flawless dermal filler described as a CE Certified hyaluronic acid dermal filler developed in South Korea, using multi Phase monophasic/biphasic technology and listed under HS code 3006700000 (preparations for chemical contraceptives or similar; classification as medical device) on TradeKorea.
  • Flawless product listings indicate non Animal derived HA, BDDE cross Linking, and multi Phase technology designed to minimise migration and clumping, consistent with CE Marked dermal filler quality and safety expectations.
  • No MHRA medicinal product licence (PL number) is associated with Flawless Deep; it is marketed as a CE Marked dermal filler (medical device) rather than a medicinal product.
  • A product leaflet/spec sheet (Flawless_Leaflet.pdf) is provided via TradeKorea as part of the manufacturer’s technical documentation, containing further specifications and instructions for use.
Injectable cross-linked hyaluronic acid dermal filler with lidocaine for deep wrinkles and facial contouring

Description

Flawless Deep Filler Lidocaine – 2 x 1ml (CE) is a CE-marked, hyaluronic acid-based dermal filler developed in South Korea and designed for the correction of moderate to deep wrinkles and for refined facial contouring. It uses a unique multi-phase, multi-layered technology combining cross-linked hyaluronic acid particles with HA gel to achieve optimal viscosity, lifting and holding power, and stability in the tissue, minimising migration and clumping. With a concentration of 20 mg/ml non-animal derived hyaluronic acid and 0.3% lidocaine for improved patient comfort, Flawless Deep is indicated for treatment of nasolabial folds, marionette lines, forehead and glabellar wrinkles, cheek and lip augmentation and non-surgical nose reshaping. The product is supplied as 2 x 1 ml pre-filled syringes with 27G 1/2” needles, intended for injection into the mid to deep dermis or subcutaneous tissue to deliver smooth, natural-looking, long-lasting volume and contour enhancement.

Bnefits

  • Premium multi-layered phasic dermal filler using a combination of cross-linked hyaluronic acid particles and HA gel for optimal viscosity and stability.
  • Effectively corrects moderate to deep wrinkles and folds, including nasolabial folds and marionette lines.
  • Enhances and refines facial contours, suitable for cheeks, lips and non-surgical nose reshaping.
  • CE-marked hyaluronic acid dermal filler developed in South Korea with multi-phase technology to minimise clumping and migration.
  • Contains 20 mg/ml non-animal derived hyaluronic acid for volumising, hydrating and supporting skin structure.
  • Includes 0.3% lidocaine to reduce pain and discomfort during injection.
  • Designed to be easily injected into mid to deep dermis or subcutis due to its optimised density and rheological properties.
  • Provides smooth, natural-looking results and long-lasting effects (typical duration for Flawless Deep quoted as around 6–12 months in brand materials).
  • High lifting and holding force at the injection site, supporting precise shaping and contour definition.
  • Supplied with sterile 27G x 1/2" needles and pre-filled syringes for professional use by trained medical practitioners.

Indications

  • Correction of moderate to deep wrinkles and folds, including nasolabial folds.
  • Treatment of marionette lines.
  • Correction of forehead wrinkles and glabella lines.
  • Cheek augmentation and contouring.
  • Lip augmentation, shaping and definition.
  • Non-surgical nose bridge contouring and reshaping.
  • General restoration of lost facial volume in mid to deep dermal or subcutaneous layers, as indicated for Flawless Deep in distributor and brand materials.

Composition

  • Hyaluronic acid (non-animal derived, cross-linked polymeric form): 20 mg/ml.
  • Lidocaine hydrochloride: 0.3% (local anaesthetic for pain reduction during injection).
  • Multi-phase structure: hyaluronic acid in cross-linked polymeric form arranged on gel particles, creating a solution with optimal viscosity and density for deep dermal and subcutaneous injections.
  • HA described as highly purified to reduce risk of adverse reactions; marketed as HA sensitivity-friendly and reversible with hyaluronidase according to brand literature.
  • Specific excipients beyond hyaluronic acid and lidocaine (e.g. buffer, stabilisers, residual cross-linking agent BDDE) are not fully listed in publicly accessible product descriptions and are therefore not publicly listed.

Formulation

  • Injectable, sterile, pyrogen-free, viscoelastic gel of cross-linked hyaluronic acid with lidocaine in pre-filled glass syringes.
  • Multi-layered, multi-phase HA technology combining monophasic and biphasic characteristics to provide strong lifting capacity and stable placement in tissues.
  • Non-animal derived, BDDE-cross-linked hyaluronic acid, CE-certified as a dermal filler.
  • Intended injection depth: mid to deep dermis and/or subcutaneous tissue depending on treatment area, as described on Flawless product pages (Flawless Deep: purpose mid/deep dermis, duration 6–12 months).
  • Delivered as two 1 ml syringes per pack with Luer-lock compatibility and supplied sterile 27G x 1/2" needles for single use.

Packaging

  • Box containing 2 x 1 ml pre-filled syringes of Flawless Deep dermal filler with lidocaine.
  • Each pack includes 2 sterile single-use needles 27G x 1/2" (13 mm).
  • Outer carton printed with Flawless branding, product name "Flawless Deep with Lidocaine", HA concentration (20 mg/ml), lidocaine content (0.3%), volume (1 ml x 2 ea) and CE marking.
  • Primary container: sterile pre-filled syringe(s) with protective caps and plunger, delivered in a blister tray within the carton.
  • Full packaging artwork, materials and storage labelling details are not fully reproduced in public web listings and so are not publicly listed beyond the above.

Usage

  • Intended for professional use only by appropriately trained and qualified medical or aesthetic practitioners; all distributors emphasise that purchasers must be trained and insured to use the product.
  • Injected into the mid to deep dermis or subcutaneous tissue depending on treatment indication (e.g. mid/deep dermis for wrinkles and folds; deeper placement for volumising and contouring areas such as cheeks or nose).
  • Typical treatment areas listed in product descriptions include: nasolabial folds, marionette lines, forehead wrinkles, glabella lines, cheeks, lips and nose bridge.
  • Supplied with 27G x 1/2" needles; injection technique (e.g. linear threading, serial puncture, fanning, bolus) and exact depth are determined by the practitioner according to clinical judgement and product leaflet guidance.
  • Flawless brand and distributors state that the multi-phase HA formulation allows easy injection even into the deep dermal layer because of its optimal density and rheological profile.
  • Product is intended as a single-use device per syringe; any unused gel must be discarded in accordance with local regulations as detailed in the Instructions for Use (IFU).
  • Detailed step-by-step injection protocols, contraindications, precautions and post-treatment care instructions are provided in the manufacturer’s leaflet/IFU (Flawless_Leaflet.pdf) and are not fully reproduced in public listings.

Contraindications

  • Not publicly listed in full detail in online sources; specific contraindications (such as hypersensitivity to hyaluronic acid or lidocaine, pregnancy, breastfeeding, autoimmune disorders, active skin infection or inflammation at the injection site, and other medical conditions) are provided in the official IFU/leaflet and must be consulted prior to use.
  • As a general principle for HA dermal fillers with lidocaine, use is contraindicated in patients with known hypersensitivity to hyaluronic acid, lidocaine or local anaesthetics of the amide type, or to any other components of the formulation; these details should be verified in the manufacturer’s documentation.

Adverse Effects

  • Not publicly listed in full detail in online product summaries; the official leaflet (Flawless_Leaflet.pdf) contains the formal adverse event profile and must be consulted before use.
  • As with other hyaluronic acid dermal fillers, expected transient injection-related reactions may include redness, swelling, pain, tenderness, bruising, itching or discolouration at the injection site; rare but serious complications such as vascular occlusion or infection are known risks of dermal filler injections and are managed according to established clinical guidelines rather than product-specific online summaries.

Storage Conditions

  • Not publicly listed in complete form on public reseller pages; standard storage conditions (such as storing in original packaging, protected from light and freezing, at controlled room/refrigerated temperature as specified on the box) are described in the product leaflet and on packaging and must be followed by users.
  • No detailed temperature range or shelf-life figures are reproduced in the publicly available web product descriptions consulted.

Duration

Typical duration for Flawless Deep given in brand and distributor materials is approximately 6\u201312 months depending on indication, injection depth and individual patient factors; some resellers quote longevity up to around 12\u201314 months for deep wrinkle and contouring treatments.

Onset

Not publicly listed (public-facing materials describe immediate volumising and contouring effects after injection but do not provide a quantified onset time).

Browse more CE-marked hyaluronic acid dermal filler (medical device)

Top Treatments

Top Cities in the UK